Clinical trial
Treatment of Diabetic Peripheral Neuropathy With Adipose-derived Stromal Vascular Fraction Cells
NCT07553468 is registered in ClinicalTrials.gov with Michael H Carstens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Diabetic Peripheral Neuropathy With Adipose-derived Stromal Vascular Fraction Cells
- Lead sponsor
- Michael H Carstens
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 1, 2024
- Completion date
- March 31, 2026
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetic foot, diabetic peripheral neuropathy